Description
It is our pleasure to present to you, on behalf of the International Psychogeriatric Association (IPA), this new webinar: An Update on Interventions for Behavioral and Psychological Symptoms of Dementia.
Behavioral and Psychological Symptoms of Dementia (BPSD) are the greatest challenge in dementia care. These symptoms have a negative impact on quality of life, and are associated with caregiver burnout and institutionalization. There are good options to reduce these symptoms. Behavioral and pharmacological interventions are meant to reduce the frequency and severity of BPSD.
In this webinar, experts in the field provided a review of interventions for BPSD and an update on the latest treatments.
As with all programs in the IPA Webinar Series, this presentation is intended as an educational event on topics that are timely and relevant to the field of mental health for older adults.
Prof. Myrra Vernooij-Dassen, PhD
Chair, IPA Webinar Series
Tuesday, 19 April 2022
Program & Presenters:
|
Opening Remarks & Moderator:
Professor Myrra Vernooij-Dassen, PhD Radboud University Nijmegen Medical Centre Chair, IPA Webinar Task Force The Netherlands |
|
Presenter: Krista L. Lanctôt, PhD Senior Scientist in Geriatric Psychiatry; Hurvitz Brain Sciences Program at Sunnybrook Research Institute Canada |
|
Presenter: Esme Moniz-Cook, PhD Professor Emerita, University of Hull UK United Kingdom Download slide deck here |
|
Panelist: Ian Andrew James, PhD NTW NHS Trust Lead Challenging Behaviour,Head of Newcastle Older People’s Services, Hon. Professor University of Bradford United Kingdom |
Program Organizers:
|
|
|
|
Prof Myrra Vernooij-Dassen, PhD
Radboud University Nijmegen Medical Centre Chair, IPA Webinar Task Force The Netherlands |
Robert Madan MD FRCPC
Deputy Chief of Staff, Baycrest, Toronto, Canada |
Prof Maria I. Lapid, MD
Professor of Psychiatry Mayo Clinic, Rochester, MN, United States |
Contributors
-
Krista L. Lanctôt, PhD
Dr. Krista L. Lanctôt has a PhD in Clinical Pharmacology from the University of Toronto, with additional training in pharmacoepidemiology.She is currently a Senior Scientist in Geriatric Psychiatry and in the Hurvitz Brain Sciences Program at Sunnybrook Research Institute, Research Co-Director in the Department of Psychiatry at Sunnybrook Health Sciences Centre and the Head of Neuropsychopharmacology Research.She holds the Bernick Chair is Geriatric Psychopharmacology. She is also a Full Professor of Psychiatry and Pharmacology/Toxicology, and Vice Chair of Basic and Clinical Sciences in the Department of Psychiatry at the University of Toronto, Toronto, Ontario, Canada.
Dr. Lanctôt is an active researcher with over 350 published papers.Her group’s research has focused on optimizing the pharmacotherapy of cognition and neuropsychiatric symptoms associated with dementia and in predementia states.She currently holds grants as a PI from the National Institutes of Health, Alzheimer’s Drug Discovery Foundation, Alzheimer’s Association US, Weston Brain Institute and Canadian Institutes of Health Research.She is a full member of the School of Graduate Studies in the Faculty of Medicine, University of Toronto, previous winner of the Faculty of Medicine Graduate Education Award, and has successfully supervised more than 35 graduate students.
-
Esme Moniz-Cook, PhD
Professor Emerita, University of Hull UK
Dr. Esme Moniz-Cook has, since 1987, worked across the trajectory of dementia care with people, families, care staff and communities in Hull, UK.Her clinical work engaged with people and their families to raise many questions, leading to psychosocial research funding for novel methods of providing care. She founded INTERDEM https://interdem.org/ with an EU award (1997-1999) ‘Early Detection and Psychosocial Rehabilitation to Maintain Quality of Life in Dementia’ and has led and collaborated on several national and international dementia care applied research programs, such as on social inclusion and rehabilitation, personalised ‘behavior support’ care people with dementia at home and in care homes and asset-based approaches to outcome measurement.
Her PhD (mid 1990’s) work on BPSD has since spanned over 25 years through several large scale collaborative research awards, practice manuals and e-learning materials. She is passionate about translating high quality research findings into practice and is currently collaborating on a national project to produce ‘BPSD’ practice toolkits to reduce distress in dementia. This aspires to help practitioners in targeting their support to minimise the use of psychotropic drugs in dementia care and to inform future NICE Dementia guidelines. -
Ian Andrew James, PhD
Ian Andrew James is Challenging Behaviour Trust Lead for Older People and Consultant Clinical Psychologist in Northumberland Tyne and Wear NHS Trust. Having graduated in Psychology from the University of Aberdeen, he undertook a PhD in cognitive psychology at Lancaster University. After completing his clinical training at Newcastle University, he spent four years at Newcastle Cognitive and Behavioural Therapies Centre, undertaking work on therapeutic competence. He has published extensively in the field of mental health, training and clinical supervision, and is a regular speaker at national and international conferences. He is an honorary professor at Bradford University, and now focuses on applying therapy to people with dementia.